Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Muhammad Wasif Saif. (2016) Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 17:3, pages 443-456.
Read now
Read now
Ben Lawrence, Malcolm Anderson, Simon Schimmack, Michael Findlay, Mark Kidd & Irvin Modlin. (2013) Neoplastic lesions of endocrine cells in the gastrointestinal tract: ten evolving principles as a basis for clinical understanding. Gastrointestinal Cancer: Targets and Therapy 3, pages 1-17.
Read now
Read now
Articles from other publishers (44)
Young Mok Park, Hyung Il Seo, Byeong Gwan Noh, Suk Kim, Seung Baek Hong, Nam Kyung Lee, Dong Uk Kim & Sung Yong Han. (2023) Clinicopathological characteristics of extrahepatic biliary neuroendocrine neoplasms in the gallbladder, extrahepatic biliary tract, and ampulla of Vater: A single-center cross-sectional study. Annals of Hepato-Biliary-Pancreatic Surgery 27:4, pages 380-387.
Crossref
Crossref
Saamia Shaikh, Logine Abouzead, Celia Leone & Toghrul Talishinskiy. (2023) A rare occurrence of a poorly differentiated large cell neuroendocrine carcinoma of the gallbladder: A case report and review of the literature. International Journal of Surgery Case Reports 109, pages 108476.
Crossref
Crossref
Rodney E. Shackelford, Ekin Ozluk, Jehan Abdulsattar, Terry C. Lairmore, Quyen Chu & Eric X. Wei. (2022) A Rare Case of Pure Primary Large Cell Neuroendocrine Carcinoma of the Gallbladder. Case Reports in Oncological Medicine 2022, pages 1-4.
Crossref
Crossref
Wei Wang, Chuan Xin Yang, Xin Zhe Yu, Shi Lei Zhang, Jie Wang & Jian Wang. (2022) Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas. Journal of Digestive Diseases 23:3, pages 166-173.
Crossref
Crossref
Aashita, Vikas Yadav, Anuja Kapoor & Rajiv Sharma. (2022) Neuroendocrine tumor gall bladder: A case report and review of literature. Journal of Medical Sciences 42:3, pages 145.
Crossref
Crossref
Christian Fottner, Thomas J. Musholt & Matthias M. Weber. 2022. Therapie-Handbuch - Onkologie und Hämatologie. Therapie-Handbuch - Onkologie und Hämatologie
391
404
.
Fatao Liu, Yongsheng Li, Dongjian Ying, Shimei Qiu, Yong He, Maolan Li, Yun Liu, Yijian Zhang, Qin Zhu, Yunping Hu, Liguo Liu, Guoqiang Li, Weihua Pan, Wei Jin, Jiasheng Mu, Yang Cao & Yingbin Liu. (2021) Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Zviadi Aburjania, Jason D. Whitt, Samuel Jang, Dwayaja H. Nadkarni, Herbert Chen, J. Bart Rose, Sadanandan E. Velu & Renata Jaskula-Sztul. (2020) Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells. Molecules 25:21, pages 4940.
Crossref
Crossref
Ming Jin, Bo Zhou, Xiong-Ling Jiang, Qi-Yi Zhang, Xiang Zheng, Yuan-Cong Jiang & Sheng Yan. (2020) Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: A case report. World Journal of Gastroenterology 26:6, pages 686-695.
Crossref
Crossref
Yung Hun You, Dong Wook Choi, Jin Seok Heo, In Woong Han, Seong Ho Choi, Kee-Taek Jang & Sunjong Han. (2019) Can surgical treatment be justified for neuroendocrine carcinoma of the gallbladder?. Medicine 98:11, pages e14886.
Crossref
Crossref
Bartholomeus J.G.A. Corten, Wouter K.G. Leclercq, M. Wouter Dercksen, Wilhelmus T. van den Broek, Peter H. van Zwam, Cees H. Dejong & Gerrit D. Slooter. (2019) Paraganglion, a pitfall in diagnosis after regular cholecystectomy. International Journal of Surgery Case Reports 65, pages 205-208.
Crossref
Crossref
Christian Fottner & Matthias Weber. (2018) Medikamentöse Therapie neuroendokriner Neoplasien des GastrointestinaltraktsMedicinal therapy of gastroenteropancreatic neuroendocrine neoplasms. Wiener klinisches Magazin 21:6, pages 250-259.
Crossref
Crossref
C. Fottner & M. M. Weber. (2017) Medikamentöse Therapie neuroendokriner Neoplasien des GastrointestinaltraktsMedicinal therapy of gastroenteropancreatic neuroendocrine neoplasms. Der Onkologe 24:2, pages 124-132.
Crossref
Crossref
Matthew H. Wong, David L. Chan, Adrian Lee, Bob T. Li, Sumit Lumba, Stephen J. Clarke, Jaswinder Samra & Nick Pavlakis. (2016) Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET). PLOS ONE 11:6, pages e0158140.
Crossref
Crossref
Salvatore Buscemi, Elisabetta Orlando, Giuseppe Damiano, Francesca Portelli, Vincenzo Davide Palumbo, Alessandro Valentino, Antonio Marrazzo, Giuseppe Buscemi & Attilio Ignazio Lo Monte. (2016) “Pure” large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature. International Journal of Surgery 28, pages S128-S132.
Crossref
Crossref
Wei Liu, Lei Wang, Xiao-dong He, Cheng Feng, Xiao-yan Chang & Zhao-hui Lu. (2015) Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature. World Journal of Surgical Oncology 13:1.
Crossref
Crossref
Sung Pil Yun. (2015) Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. World Journal of Gastroenterology 21:1, pages 269.
Crossref
Crossref
C. Fottner & M.M. Weber. 2015. Therapie-Handbuch Grundwerk inkl 6. Lfg.. Therapie-Handbuch Grundwerk inkl 6. Lfg.
1
15
.
Federica Barbieri, Manuela Albertelli, Federica Grillo, Amira Mohamed, Alexandru Saveanu, Anne Barlier, Diego Ferone & Tullio Florio. (2014) Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies. Drug Discovery Today 19:4, pages 458-468.
Crossref
Crossref
David S. Klimstra. (2013) Pathology Reporting of Neuroendocrine Tumors: Essential Elements for Accurate Diagnosis, Classification, and Staging. Seminars in Oncology 40:1, pages 23-36.
Crossref
Crossref
Yash Somnay, Kevin Simon, April D. Harrison, Selvi Kunnimalaiyaan, Herbert Chen & Muthusamy Kunnimalaiyaan. (2013) Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro. Anti-Cancer Drugs 24:1, pages 66-72.
Crossref
Crossref
Irina Velikyan, Hui Xu, Manoj Nair & Håkan Hall. (2012) Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nuclear Medicine and Biology 39:5, pages 628-639.
Crossref
Crossref
Nancy M. Gardner-Roehnelt. (2012) Update on the Management of Neuroendocrine Tumors: Focus on Somatostatin Antitumor Effects. Clinical Journal of Oncology Nursing 16:1, pages 56-64.
Crossref
Crossref
M. D. Miljković, M. Girotra, R. R. Abraham & R. B. Erlich. (2011) Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. Digestive Diseases and Sciences 57:1, pages 9-18.
Crossref
Crossref
Irvin M. Modlin, Steven F. Moss, Bjorn I. Gustafsson, Ben Lawrence, Simon Schimmack & Mark Kidd. (2011) The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant. Langenbeck's Archives of Surgery 396:8, pages 1145-1156.
Crossref
Crossref
K Landerholm, N Zar, R E Andersson, S E Falkmer & J Järhult. (2011) Survival and prognostic factors in patients with small bowel carcinoid tumour. British Journal of Surgery 98:11, pages 1617-1624.
Crossref
Crossref
Yoshio Yoshida, Kumiko Sato, Kanji Katayama, Akio Yamaguchi, Yoshiaki Imamura & Fumikazu Kotsuji. (2011) Atypical metastatic carcinoid of the uterine cervix and review of the literature. Journal of Obstetrics and Gynaecology Research 37:6, pages 636-640.
Crossref
Crossref
Scott R. Silva, Kanika A. Bowen, Piotr G. Rychahou, Lindsey N. Jackson, Heidi L. Weiss, Eun Y. Lee, Courtney M. TownsendJr.Jr. & B. Mark Evers. (2010) VEGFR‐2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. International Journal of Cancer 128:5, pages 1045-1056.
Crossref
Crossref
Yi-Ping Zou, Wei-Min Li, Hao-Run Liu & Ning Li. (2010) Primary carcinoid tumor of the gallbladder: A case report and brief review of the literature. World Journal of Surgical Oncology 8:1.
Crossref
Crossref
Maya B. Lodish & Constantine A. Stratakis. (2010) Rare and Unusual Endocrine Cancer Syndromes With Mutated Genes. Seminars in Oncology 37:6, pages 680-690.
Crossref
Crossref
Karim M. Eltawil, Bjorn I. Gustafsson, Mark Kidd & Irvin M. Modlin. (2010) Neuroendocrine Tumors of the Gallbladder. Journal of Clinical Gastroenterology 44:10, pages 687-695.
Crossref
Crossref
R. Garcia-Carbonero, J. Capdevila, G. Crespo-Herrero, J.A. Díaz-Pérez, M.P. Martínez del Prado, V. Alonso Orduña, I. Sevilla-García, C. Villabona-Artero, A. Beguiristain-Gómez, M. Llanos-Muñoz, M. Marazuela, C. Alvarez-Escola, D. Castellano, E. Vilar, P. Jiménez-Fonseca, A. Teulé, J. Sastre-Valera, M. Benavent-Viñuelas, A. Monleon & R. Salazar. (2010) Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Annals of Oncology 21:9, pages 1794-1803.
Crossref
Crossref
David S. Klimstra, Irvin R. Modlin, N. Volkan Adsay, Runjan Chetty, Vikram Deshpande, Mithat Gönen, Robert T. Jensen, Mark Kidd, Matthew H. Kulke, Ricardo V. Lloyd, Cesar Moran, Steven F. Moss, Kjell Oberg, Dermot O'Toole, Guido Rindi, Marie E. Robert, Saul Suster, Laura H. Tang, Chin-Yuan Tzen, Mary Kay Washington, Betram Wiedenmann & James Yao. (2010) Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set. American Journal of Surgical Pathology 34:3, pages 300-313.
Crossref
Crossref
Katharina Ruebel, Alexey A Leontovich, Gail A Stilling, Shuya Zhang, Alberto Righi, Long Jin & Ricardo V Lloyd. (2010) MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression. Modern Pathology 23:3, pages 367-375.
Crossref
Crossref
Katharina M. Detjen, Svenja Rieke, Antje Deters, Petra Schulz, Annett Rexin, Sonja Vollmer, Peter Hauff, Bertram Wiedenmann, Marianne Pavel & Arne Scholz. (2010) Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors. Clinical Cancer Research 16:2, pages 420-429.
Crossref
Crossref
I. M. MODLIN, M. PAVEL, M. KIDD & B. I. GUSTAFSSON. (2009) Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Alimentary Pharmacology & Therapeutics 31:2, pages 169-188.
Crossref
Crossref
Kris V. Kowdley. 2010. Netter's Gastroenterology. Netter's Gastroenterology
681
682
.
Giovanni Lucignani & Emilio Bombardieri. (2009) Progress and challenges in neuroendocrine and neural crest tumours: molecular imaging and therapy. European Journal of Nuclear Medicine and Molecular Imaging 36:12, pages 2081-2088.
Crossref
Crossref
Federica BarbieriAlessandra PattarozziMonica GattiCinzia AielloAna QuinteroGianluigi LunardiAdriana BajettoAngelo Ferrari, Michael D. Culler & Tullio Florio. (2009) Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. American Journal of Physiology-Endocrinology and Metabolism 297:5, pages E1078-E1088.
Crossref
Crossref
Vishal Ghevariya, Anju Malieckal, Nehal Ghevariya, Mohammed Mazumder & Sury Anand. (2009) Carcinoid Tumors of the Gastrointestinal Tract. Southern Medical Journal 102:10, pages 1032-1040.
Crossref
Crossref
Nikiforos Ballian, Agnes G. Loeffler, Victoria Rajamanickam, Peter A. Norstedt, Sharon M. Weber & Clifford S. Cho. (2009) A simplified prognostic system for resected pancreatic neuroendocrine neoplasms. HPB 11:5, pages 422-428.
Crossref
Crossref
J A Søreide. (2009)
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease (
Br J Surg
2009; 96: 175–184)
. British Journal of Surgery 96:7, pages 823-823.
Crossref
Crossref
R. SRIRAJASKANTHAN, C. TOUMPANAKIS, T. MEYER & M. E. CAPLIN. (2009) Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Alimentary Pharmacology & Therapeutics 29:11, pages 1143-1154.
Crossref
Crossref
T.J. Musholt & H. Lang. (2009) Indikatorisches und operatives Spektrum bei neuroendokrinen LebermetastasenIndications and operative procedures for neuroendocrine liver metastases. Der Chirurg 80:2, pages 113-121.
Crossref
Crossref